Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 2023
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Cell
|
September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel, Christian Posch, Steven R Barthel, et al.
JAMA Dermatology
|
March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group
Emanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 4, 2015
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
Emmanuella Guenova, Yuliya Skabytska, Wolfram Hoetzenecker, et al.
JAAD International
|
August 19, 2021
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
Thomas Graier, Wolfgang Weger, Paul-Gunther Sator, et al.
The British Journal of Dermatology
|
October 12, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study
Thomas Graier, Natalie Bordag, Wolfgang Weger, et al.
The Journal of Investigative Dermatology
|
July 3, 2024
Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics
Petra Doerfler, Nicole Schoefmann, Gabriela Cabral, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2021
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Allergy
|
February 19, 2021
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy
Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, et al.
Contact Dermatitis
|
December 31, 2021
Guidelines for diagnosis, prevention, and treatment of hand eczema
Jacob P Thyssen, Marie L A Schuttelaar, Jose H Alfonso, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 2023
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Cell
|
September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel, Christian Posch, Steven R Barthel, et al.
JAMA Dermatology
|
March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group
Emanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 4, 2015
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
Emmanuella Guenova, Yuliya Skabytska, Wolfram Hoetzenecker, et al.
JAAD International
|
August 19, 2021
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
Thomas Graier, Wolfgang Weger, Paul-Gunther Sator, et al.
The British Journal of Dermatology
|
October 12, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study
Thomas Graier, Natalie Bordag, Wolfgang Weger, et al.
The Journal of Investigative Dermatology
|
July 3, 2024
Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics
Petra Doerfler, Nicole Schoefmann, Gabriela Cabral, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2021
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Allergy
|
February 19, 2021
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy
Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, et al.
Contact Dermatitis
|
December 31, 2021
Guidelines for diagnosis, prevention, and treatment of hand eczema
Jacob P Thyssen, Marie L A Schuttelaar, Jose H Alfonso, et al.
Page
of 12